Working… Menu
Trial record 3 of 408 for:    ARIPIPRAZOLE

A Trial of Multiple-doses of Aripiprazole in Adults With Schizophrenia or Bipolar 1 Disorder

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04030143
Recruitment Status : Recruiting
First Posted : July 23, 2019
Last Update Posted : September 23, 2019
PRA Health Sciences
Information provided by (Responsible Party):
Otsuka Pharmaceutical Development & Commercialization, Inc.

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : April 24, 2021
Estimated Study Completion Date : April 24, 2021